Vitamin D deficiency, a potential cause for insufficient response to sildenafil in pulmonary arterial hypertension

Eur Respir J. 2021 Nov 4;58(5):2101204. doi: 10.1183/13993003.01204-2021. Print 2021 Oct.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Familial Primary Pulmonary Hypertension / drug therapy
  • Humans
  • Pulmonary Arterial Hypertension*
  • Sildenafil Citrate
  • Vasodilator Agents / therapeutic use
  • Vitamin D Deficiency* / complications
  • Vitamin D Deficiency* / drug therapy

Substances

  • Vasodilator Agents
  • Sildenafil Citrate